Industry

PARSIPPANY, N.J.–(BUSINESS WIRE)–$ZTS #Fortune500—Zoetis Inc. (NYSE:ZTS) will participate in the Morgan Stanley 20th Annual Global Healthcare Conference on Tuesday, September 13, 2022. Wetteny Joseph, Executive Vice President and Chief Financial Officer, will represent the company and respond to questions from analysts. He is scheduled to present at 2:05 p.m. ET. Investors and other interested parties … [Read more…]

CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV), a research and clinical-stage biomaterials and biotechnology company with a focus on the treatment of spinal cord injuries, today announced that Richard Toselli, M.D., President and Chief Executive Officer, will present at the upcoming H.C. Wainwright 24th Annual Global Investment Conference, which runs from September 12 – … [Read more…]

– Renowned reproductive health expert Dr. Robert Auerbach, OBGYN, appointed chairman of the board – May Health, formerly AblaCare, changes its name to reflect focus on restoring the lives of those with PCOS PARIS–(BUSINESS WIRE)–May Health, a clinical-stage medical device company dedicated to helping those living with the endocrine disorder polycystic ovary syndrome (PCOS), today … [Read more…]

Treatment with KIF18A inhibitor led to substantial, dose-dependent inhibition of tumor growth in multiple tumor models, with no effect on normal cells KIF18A inhibitor on track to enter the clinic in 2H 2023 NEW YORK–(BUSINESS WIRE)–Volastra Therapeutics, an oncology company focused on exploiting chromosomal instability (CIN), today announced new data from its lead program, a … [Read more…]

National medical group files lawsuit, urging health insurer to pay its bills and fairly reimburse clinicians providing life-saving emergency care to patients across the country NASHVILLE, Tenn.–(BUSINESS WIRE)–Envision Healthcare, a leading national medical group, filed suit against UnitedHealthcare Services, Inc. and UnitedHealthcare Insurance Company (“United”) in U.S. federal court in Tennessee. The suit claims that … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “US Colorectal Cancer Market and Competitive Landscape – 2022” report has been added to ResearchAndMarkets.com’s offering. The report provides comprehensive insights into Colorectal Cancer pipeline products, Colorectal Cancer epidemiology, Colorectal Cancer market valuations and forecast, Colorectal Cancer drugs sales and competitive landscape in the US. The research is classified into seven sections – … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “US Melanoma Market and Competitive Landscape – 2022” report has been added to ResearchAndMarkets.com’s offering. The report provides comprehensive insights into Melanoma pipeline products, Melanoma epidemiology, Melanoma market valuations and forecast, Melanoma drugs sales and competitive landscape in the US. The research is classified into seven sections – Melanoma treatment options, pipeline products, … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Doxorubicin Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Drug Formulation, Application, and Distribution Channel” report has been added to ResearchAndMarkets.com’s offering. The global doxorubicin market is projected to reach US$ 1,983.40 million by 2028 from US$ 1,390.64 million in 2022; it is expected to register a CAGR of 6.1% … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Cardiac Markers Rapid Tests and POC Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update” report has been added to ResearchAndMarkets.com’s offering. This report provides comprehensive information about the Cardiac Markers Rapid Tests & POC pipeline products with comparative analysis of the products at various … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Biostimulants Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Product, Mode of Application, and Crop Type” report has been added to ResearchAndMarkets.com’s offering. The biostimulants market is expected to grow from US$ 3,112.49 million in 2022 to US$ 5,796.94 million by 2028; it is estimated to grow at a CAGR … [Read more…]